Antonio Gutiérrez-Ramírez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Antonio Gutiérrez-Ramírez has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Agustina Rosas-Baruch
Department of Medicaments, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City 14080, Mexico
1 shared publication - Alejandra Valdivia-Flores
Department of Research, Hospital Juarez of Mexico, Mexico City 07760, Mexico
1 shared publication - Erika Gómez-Zamora
Department of Medical Management, Hospital Juarez of Mexico, Mexico City 07760, Mexico
1 shared publication - José Ángel Hernández-Mariano
Department of Research, Hospital Juarez of Mexico, Mexico City 07760, Mexico
1 shared publication - Marco Antonio León Mazón
Family Medicine Unit No. 20, Mexican Social Security Institute, Cuernavaca 62000, Mexico
1 shared publication - María G. Ortiz-López
Department of Research, Hospital Juarez of Mexico, Mexico City 07760, Mexico
1 shared publication
Latest Publications
- Open Access
COVID-19 and Its Association with Hypertensive Disorders of Pregnancy and Preterm Birth: A Retrospective Cohort Study
Background: COVID-19 during pregnancy has been associated with various obstetric complications; however, epidemiological evidence regarding its relationship with hypertensive disorders of pregnancy (HDP) and preterm birth remains inconclusive. Therefore, we aimed to evaluate the association between COVID-19 during pregnancy and the risk of HDP and preterm birth among Mexican pregnant women. Methods: We conducted a retrospective cohort study based on a review of 3710 medical records of women treated at a tertiary hospital between 2020 and 2023. COVID-19 was diagnosed by real-time reverse transcription polymerase chain reaction (RT-PCR) assay. We estimated adjusted risk ratios (aRRs) using robust Poisson regression models, controlling for potential confounders. Results: The COVID-19 rate was 2.5%. We observed that women with COVID-19 had a higher risk of HDP (aRR = 1.59; 95% CI = 1.07–2.36). When HDP subgroups were analyzed separately, COVID-19 was associated with an increased risk of preeclampsia (aRR = 2.04; 95% CI = 1.34–4.20) and preterm birth (aRR = 1.50; 95% CI = 1.02–2.19). The association with gestational hypertension lost statistical significance after adjustment. Conclusions: Our findings suggest that COVID-19 during pregnancy may be associated with hypertensive disorders of pregnancy and preterm birth. However, the observed association with preeclampsia should be interpreted cautiously because diagnostic overlap between severe COVID-19 and preeclampsia cannot be excluded.
Open AccessCOVID-19 and Its Association with Hypertensive Disorders of Pregnancy and Preterm Birth: A Retrospective Cohort Study
Background: COVID-19 during pregnancy has been associated with various obstetric complications; however, epidemiological evidence regarding its relationship with hypertensive disorders of pregnancy (HDP) and preterm birth remains inconclusive. Therefore, we aimed to evaluate the association between COVID-19 during pregnancy and the risk of HDP and preterm birth among Mexican pregnant women. Methods: We conducted a retrospective cohort study based on a review of 3710 medical records of women treated at a tertiary hospital between 2020 and 2023. COVID-19 was diagnosed by real-time reverse transcription polymerase chain reaction (RT-PCR) assay. We estimated adjusted risk ratios (aRRs) using robust Poisson regression models, controlling for potential confounders. Results: The COVID-19 rate was 2.5%. We observed that women with COVID-19 had a higher risk of HDP (aRR = 1.59; 95% CI = 1.07–2.36). When HDP subgroups were analyzed separately, COVID-19 was associated with an increased risk of preeclampsia (aRR = 2.04; 95% CI = 1.34–4.20) and preterm birth (aRR = 1.50; 95% CI = 1.02–2.19). The association with gestational hypertension lost statistical significance after adjustment. Conclusions: Our findings suggest that COVID-19 during pregnancy may be associated with hypertensive disorders of pregnancy and preterm birth. However, the observed association with preeclampsia should be interpreted cautiously because diagnostic overlap between severe COVID-19 and preeclampsia cannot be excluded.